In Vivo Regulation of Erythropoiesis by Chemically Inducible Dimerization of the Erythropoietin Receptor Intracellular Domain

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Suzuki, Norio ^a   Mukai, Harumi Y ^a   Yamamoto, Masayuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; TRANSCRIPTION FACTOR GATA 1; AP20187; ERYTHROPOIETIN; GATA1 PROTEIN, MOUSE; TACROLIMUS;

ADULT; AMINO ACID SEQUENCE; ANEMIA; ARTICLE; CHEMICALLY INDUCED DIMERIZATION; CONTROLLED STUDY; DIMERIZATION; EMBRYO; ERYTHROPOIESIS; GATA1 GENE; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; REGULATORY MECHANISM; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MUS MUSCULUS;

AMINO ACID SEQUENCE; ANEMIA; ANIMALS; ERYTHROPOIESIS; ERYTHROPOIETIN; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, TRANSGENIC; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; TACROLIMUS;

EID: 84925436676     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119442     Document Type: Article

References (45)

1. Jelkmann W. Physiology and pharmacology of erythropoietin. Transfus Med Hemother. 2013; 40: 302-309. doi: 10.1159/000356193 PMID: 24273483
2. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 1995; 83: 59-67. PMID: 7553874
3. Koury MJ. Abnormal erythropoiesis and the pathophysiology of chronic anemia. Blood Rev. 2014; 28: 49-66. doi: 10.1016/j.blre.2014.01.002 PMID: 24560123
4. Miyata T, Suzuki N, van Ypersele de Strihou C. Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology? Kidney Int. 2013; 84: 693-702. doi: 10.1038/ki.2013.74 PMID: 23486514
5. Souma T, Yamazaki S, Moriguchi T, Suzuki N, Hirano I, Pan X, et al. Plasticity of renal erythropoietin-producing cells governs fibrosis. J Am Soc Nephrol. 2013; 24: 1599-1616. doi: 10.1681/ASN.2013010030 PMID: 23833259
6. Suzuki N, Obara N, Yamamoto M. Use of gene-manipulated mice in the study of erythropoietin gene expression. Methods Enzymol. 2007; 435: 157-177. PMID: 17998054
7. Bunn HF. New agents that stimulate erythropoiesis. Blood. 2007; 109: 868-873. PMID: 17032916
8. Pollock C, Johnson DW, H WH, Rossert J, Casadevall N, Schellekens H, et al. Pure red cell aplasia induced by erythropoiesis-stimulating agents. Clin J Am Soc Nephrol. 2008; 3: 193-199. doi: 10.2215/CJN.02440607 PMID: 18178785
9. Wojchowski DM, Sathyanarayana P, Dev A. Erythropoietin receptor response circuits. Curr Opin Hematol. 2010; 17: 169-176. doi: 10.1097/MOH.0b013e328338008b PMID: 20173635
10. Elliott S, Pham E, Macdougall IC. Erythropoietins: A common mechanism of action. Exp Hematol. 2008; 36: 1573-1584. doi: 10.1016/j.exphem.2008.08.003 PMID: 18922615
11. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 1999; 283: 987-990. PMID: 9974392
12. Frank SJ. Receptor dimerization in GH and erythropoietin action-it takes two to tango, but how? Endocrinology. 2002; 143: 2-10. PMID: 11751584
13. Huang LJ, Constantinescu SN, Lodish HF. The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell. 2001; 8: 1327-1338. PMID: 11779507
14. Miller CP, Blau CA. Using gene transfer to circumvent off-target effects. Gene Ther. 2008; 15: 759-764. doi: 10.1038/gt.2008.43 PMID: 18356813
15. Spencer DM, Wandless TJ, Schreiber SL, Crabtree GR. Controlling signal transduction with synthetic ligands. Science. 1993; 262: 1019-1024. PMID: 7694365
16. Blau CA, Peterson KR, Drachman JG, Spencer DM. A proliferation switch for genetically modified cells. Proc Natl Acad Sci U S A. 1997; 94: 3076-3081. PMID: 9096348
17. Jin L, Asano H, Blau CA. Stimulating cell proliferation through the pharmacologic activation of c-kit. Blood. 1998; 91: 890-897. PMID: 9446649
18. Jin L, Zeng H, Chien S, Otto KG, Richard RE, Emery DW, et al. In vivo selection using a cell-growth switch. Nat Genet. 2000; 26: 64-66. PMID: 10973250
19. Zeng H, Masuko M, Jin L, Neff T, Otto KG, Blau CA. Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells. Blood. 2001; 98: 328-334. PMID: 11435300
20. Blau CA, Peterson KR. Establishment of cell lines that exhibit correct ontogenic stage-specific gene expression profiles from tissues of yeast artificial chromosome transgenic mice using chemically induced growth signals. Methods Mol Biol. 2006; 349: 163-173. PMID: 17071982
21. Onodera K, Takahashi S, Nishimura S, Ohta J, Motohashi H, Yomogida K, et al. GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proc Natl Acad Sci U S A. 1997; 94: 4487-4492. PMID: 9114016
22. Takahashi S. Shimizu R, Suwabe N, Kuroha T, Yoh K, Ohta J, et al. GATA factor transgenes under GATA-1 locus control rescue germline GATA-1 mutant deficiencies. Blood. 2000; 96: 910-916. PMID: 10910904
23. Suzuki N, Ohneda O, Takahashi S, Higuchi M, Mukai HY, Nakahata T, et al. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood. 2002; 100: 2279-2288. PMID: 12239135
24. Miller CP, Liu ZY, Noguchi CT, Wojchowski DM. A minimal cytoplasmic subdomain of the erythropoietin receptor mediates erythroid and megakaryocytic cell development. Blood. 1999; 94: 3381-3387. PMID: 10552947
25. Suzuki N, Suwabe N, Ohneda O, Obara N, Imagawa S, Pan X, et al. Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. Blood. 2003; 102: 3575-3583. PMID: 12893747
26. Otto KG, Broudy VC, Lin NL, Parganas E, Luthi JN, Drachman JG, et al. Membrane localization is not required for Mpl function in normal hematopoietic cells. Blood. 2001; 98: 2077-2083. PMID: 11567993
27. Pelletier S, Gingras S, Funakoshi-Tago M, Howell S, Ihle JN. Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function. Mol Cell Biol. 2006; 26: 8527-8538. PMID: 16982687
28. Alami R, Greally JM, Tanimoto K, Hwang S, Feng YQ, Engel JD, et al. Beta-globin YAC transgenes exhibit uniform expression levels but position effect variegation in mice. Hum Mol Genet. 2000; 9: 631-636. PMID: 10699186
29. Motohashi H, Katsuoka F, Shavit JA, Engel JD, Yamamoto M. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell. 2000; 103: 865-875. PMID: 11136972
30. Kim K, Suzuki N, Ohneda K, Minegishi N, Yamamoto M. Fractionation of mature eosinophils in GATA-reporter transgenic mice. Tohoku J Exp Med. 2010; 220: 127-138. PMID: 20139664
31. Ohmori S, Takai J, Ishijima Y, Suzuki M, Moriguchi T, Philipsen S, et al. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages. Mol Cell Biol. 2012; 32: 4742-4755. doi: 10.1128/MCB.00718-12 PMID: 22988301
32. Gross AW, Lodish HF. Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). J Biol Chem. 2006; 281: 2024-2032. PMID: 16286456
33. Flint-Ashtamker G, Eisen-Lev R, Cohen J, Jun-shen Huang L, Neumann D. Amino acid residues 268-276 of the erythropoietin receptor contain an endocytosis motif and are required for erythropoietin-mediated proliferation. FEBS Lett. 2002; 518: 189-194. PMID: 11997044
34. Ketteler R, Heinrich AC, Offe JK, Becker V, Cohen J, Neumann D, et al. A functional green fluorescent protein-erythropoietin receptor despite physical separation of JAK2 binding site and tyrosine residues. J Biol Chem. 2002; 277: 26547-26552. PMID: 11997394
35. Yoshimura A, D'Andrea AD, Lodish HF. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci U S A. 1990; 87: 4139-4143. PMID: 2161534
36. Broudy VC, Lin N, Brice M, Nakamoto B, Papayannopoulou T. Erythropoietin receptor characteristics on primary human erythroid cells. Blood. 1991; 77: 2583-2590. PMID: 1646044
37. Menon MP, Karur V, Bogacheva O, Bogachev O, Cuetara B, Wojchowski DM. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. J Clin Invest. 2006; 116: 683-694. PMID: 16511603
38. Socolovosky M, Nam H-S, Fleming MD, Haase VH, Burgnara C, Lodish HF. Ineffective erythropoiesis in Stat5a-/-5b-/-mice due to decreased survival of early erythroblastosis. Blood. 2001; 98: 3261-3273. PMID: 11719363
39. Suzuki N, Obara N, Pan X, Watanabe M, Jishage K, Minegishi N, et al. Specific contribution of the erythropoietin gene 3′ enhancer to hepatic erythropoiesis after late embryonic stages. Mol Cell Biol. 2011; 31: 3896-3905. doi: 10.1128/MCB.05463-11 PMID: 21746884
40. Suzuki M, Ohneda K, Hosoya-Ohmura S, Tsukamoto S, Ohneda O, Philipsen S, et al. Real-time monitoring of stress erythropoiesis in vivo using Gata1 and beta-globin LCR luciferase transgenic mice. Blood. 2006; 108: 726-733. PMID: 16537808
41. Zhou X, Di Stasi A, Tey SK, Krance RA, Martinez C, Leung KS, et al. Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. Blood. 2014; 123: 3895-3905. doi: 10.1182/blood-2014-01-551671 PMID: 24753538
42. Ohneda K, Shimizu R, Nishimura S, Muraosa Y, Takahashi S, Engel JD, et al. A minigene containing four discrete cis elements recapitulates GATA-1 gene expression in vivo. Genes Cells. 2002; 7: 1243-1254. PMID: 12485164
43. Arumugam PI, Higashimoto T, Urbinati F, Modlich U, Nestheide S, Xia P, et al. Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region. Mol Ther. 2009; 17: 1929-1937. doi: 10.1038/mt.2009.183 PMID: 19707188
44. Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 1998; 93: 397-409. PMID: 9590174
45. Zang H, Sato K, Nakajima H, McKay C, Ney PA, Ihle JN. The distal region and receptor tyrosines of the EPO receptor are non-essential for in vivo erythropoiesis. EMBO J. 2001; 20: 3156-3166. PMID: 11406592